Dr. Naveed U. Saqib, MD

Dr. Saqib practices at Bay Area Vascular Center in Houston, Texas.

Dr. Saqib's NPI, 1033258041, was assigned on February 6, 2007. Dr. Saqib graduated from King Edward Medical University in 2003. Dr. Saqib holds Texas license P3439.

Dr. Saqib's primary practice is Bay Area Vascular Center, at 8537 Gulf Freeway, Ste C, Houston, TX 77017. The practice phone is (832) 386-0900.

Dr. Saqib's primary practice is Bay Area Vascular Center in Houston, Texas. Dr. Saqib is also affiliated with The University of Texas MD Anderson Cancer Center. The medical group on file is UT Physicians. Dmand AI also links Dr. Saqib to 4 more hospitals, 13 medical groups and 12 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Saqib practices, 18 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Saqib's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Saqib is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Saqib's licenses on file in 3 states: Texas, Pennsylvania and New Mexico.

Dmand AI lists amputation, aortic atherosclerois, arterial blot clot /embolism, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT) and heart device and aorta surgery among the conditions Dr. Saqib treats.

CMS data shows 5,918 Medicare services from Dr. Saqib across 27 procedure codes in 2024, for 396 Medicare patients. Medicare paid $622,926 for them.

CMS counts 396 Medicare patients who saw Dr. Saqib in 2024. The largest group is 75 to 84, with 157 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 3.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Saqib's median patient age at 69, with 43% women.

In 2024, Dr. Saqib wrote 434 Medicare Part D claims for 291 patients. 97% of them were for generic drugs. CMS names the drug for 377 of them, across 3 drugs with 11 or more claims each, at $3,707 in total drug cost. In 2023, CMS named 391 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Saqib for performance year 2024, reported as part of a group. Dr. Saqib accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Saqib as offering telehealth. CMS counts 107 procedures of leg revascularization (restoring blood flow) by Dr. Saqib, more than 98% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 59 papers to Dr. Saqib, published from 2011 to 2024. 2022 was the busiest year, with 10. The most frequent topics are Endovascular Procedures, Blood Vessel Prosthesis Implantation and Aortic Aneurysm, Thoracic. Dr. Saqib has published most often in J Vasc Surg. Dr. Saqib's most frequent co-authors are Hazim J. Safi, MD, Kristofer M. Charlton-Ouw, MD and Anthony L. Estrera, MD.

Dmand AI links Dr. Saqib to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Arteriovenous Fistula and Vascular Fistula.

CMS Open Payments shows 527 general payments to Dr. Saqib from 54 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 49% of the total. Medtronic, Inc. paid the most, $23,616. It also lists 4 research payments totaling $3,315 in 2025.

Dr. Saqib graduated from King Edward Medical University in 2003.

Dr. Saqib is in network with 23 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.